# The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy

> **NCT02467647** · PHASE1 · UNKNOWN · sponsor: **Wuhan University** · enrollment: 500 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Thalidomide
- **DRUG:** HLJDT

## Key facts

- **NCT ID:** NCT02467647
- **Lead sponsor:** Wuhan University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2018-12
- **Final completion:** 2019-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2015-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02467647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02467647, "The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02467647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*